Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon-α (IFN-α) therapy
- 1 October 1995
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 84 (1) , 15-18
- https://doi.org/10.1016/0165-4608(95)00029-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Application of chromosome microdissection probes for elucidation of BCR- ABL fusion and variant Philadelphia chromosome translocations in chronic myelogenous leukemiaBlood, 1993
- Complex translocation involving Ph chromosome in a patient with typical chronic myelogenous leukemiaCancer Genetics and Cytogenetics, 1992
- A complex chromosome rearrangement forms the BCR‐ABL fusion gene in leukemic cells with a normal karyotypeGenes, Chromosomes and Cancer, 1991
- Interferon-Alpha Produces Sustained Cytogenetic Responses in Chronic Myelogenous LeukemiaAnnals of Internal Medicine, 1991
- Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapseBlood, 1991
- Detection of bcr - abl Fusion in Chronic Myelogeneous Leukemia by in Situ HybridizationScience, 1990
- Detection of the Philadelphia chromosome in interphase nucleiCytogenetic and Genome Research, 1990
- Rejoining between 9q+ and Philadelphia chromosomes results in normal-looking chromosomes 9 and 22 in Ph1-negative chronic myelocytic leukemiaHuman Genetics, 1989
- Molecular analysis of interferon-induced suppression of Philadelphia chromosome in patients with chronic myeloid leukemiaBlood, 1987
- Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1986